The National Lipid Association’s new recommendations for patient-centered management of cholesterol

Q Medicine

Clinical Lipidology Pub Date : 2015-02-01 DOI:10.2217/CLP.14.68

James A. Underberg

引用次数: 0

Abstract

James Underberg, MD, is a clinical assistant professor of medicine and clinical lipidologist at New York University Medical School and the NYU Center for Prevention of Cardiovascular Disease. He is the Director of the Lipid Clinic at Bellevue Hospital in New York City. He is also a member of the board of directors of the National Lipid Association, and serves on the scientific advisory board of the FH Foundation. He serves on the editorial board of the Journal of Clinical Lipidology. Dr. Underberg's clinical interests focus on the clinical management of patients with lipids and lipoprotein disorders, hypertension management and cardiovascular disease prevention. He maintains an active clinical research program in these areas and has authored numerous articles and book chapters in the field of clinical lipidology.

查看原文本刊更多论文

国家脂质协会关于以病人为中心的胆固醇管理的新建议

医学博士James Underberg是纽约大学医学院和纽约大学心血管疾病预防中心的临床医学助理教授和临床血脂学家。他是纽约市贝尔维尤医院脂质诊所的主任。他也是the National脂质协会的董事会成员，并在FH Foundation的科学顾问委员会任职。他是Journal of Clinical Lipidology的编辑委员会成员。Underberg博士的临床兴趣集中在脂质和脂蛋白紊乱患者的临床管理，高血压管理和心血管疾病预防。他在这些领域保持着积极的临床研究计划，并在临床脂质学领域撰写了许多文章和书籍章节。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Lipidology 生物-生化与分子生物学

CiteScore

0.44

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： The Journal of Clinical Lipidology is published to support the diverse array of medical professionals who work to reduce the incidence of morbidity and mortality from dyslipidemia and associated disorders of lipid metabolism. The Journal''s readership encompasses a broad cross-section of the medical community, including cardiologists, endocrinologists, and primary care physicians, as well as those involved in the treatment of such disorders as diabetes, hypertension, and obesity. The Journal also addresses allied health professionals who treat the patient base described above, such as pharmacists, nurse practitioners and dietitians. Because the scope of clinical lipidology is broad, the topics addressed by the Journal are equally diverse. Typical articles explore lipidology as it is practiced in the treatment setting, recent developments in pharmacological research, reports of treatment and trials, case studies, the impact of lifestyle modification, and similar academic material of interest to the practitioner. While preference is given to material of immediate practical concern, the science that underpins lipidology is forwarded by expert contributors so that evidence-based approaches to reducing cardiovascular and coronary heart disease can be made immediately available to our readers. Sections of the Journal will address pioneering studies and the clinicians who conduct them, case studies, ethical standards and conduct, professional guidance such as ATP and NCEP, editorial commentary, letters from readers, National Lipid Association (NLA) news and upcoming event information, as well as abstracts from the NLA annual scientific sessions and the scientific forums held by its chapters, when appropriate.